Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
Condition:   Breast CancerIntervention:   Radiation: TrastuzumabSponsors:   Northwestern University;   Northwestern UniversityRecruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2011 Category: Research Source Type: clinical trials

Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
Condition:   Breast CancerIntervention:   Radiation: TrastuzumabSponsor:   Northwestern UniversityRecruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2011 Category: Research Source Type: clinical trials

Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
Condition:   Breast CancerIntervention:   Radiation: TrastuzumabSponsor:   Northwestern UniversityRecruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2011 Category: Research Source Type: clinical trials

Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
Condition:   Breast CancerIntervention:   Radiation: TrastuzumabSponsor:   Northwestern UniversityRecruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2011 Category: Research Source Type: clinical trials